Physiomics (PYC)

Sector:

Health Care

Index:

FTSE AIM All-Share

0.44p
   
  • Change Today:
    -0.040p
  • 52 Week High: 1.40
  • 52 Week Low: 0.39
  • Currency: UK Pounds
  • Shares Issued: 203.21m
  • Volume: 6,850,871
  • Market Cap: £0.89m
  • RiskGrade: 504
  • Beta: 0.02

Physiomics Overview

Physiomics’ vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -123.5% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 1.6 n/a
Pr/Book 3.2  
Latest F'cast
Revenue -9.1% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Physiomics Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-20 0.80 (0.13) (0.09)p n/a n/a n/a n/a 0.0%
30-Jun-21 0.70 (0.34) (0.22)p n/a n/a n/a n/a 0.0%
30-Jun-22 0.83 (0.36) (0.26)p n/a n/a n/a n/a 0.0%
30-Jun-23 0.60 (0.57) (0.49)p n/a n/a n/a n/a 0.0%
30-Jun-24 0.54 (0.67) (0.45)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Physiomics Company Announcements

AIM Rule 17 and Schedule 2(g) Update 07-May-2025 16:45 RNS
Contract Award with new client 17-Mar-2025 07:00 RNS
Interim Results 06-Mar-2025 07:00 RNS

Physiomics ShareCast News

Physiomics project gets regulatory and ethical a... 08-Jan-2025 ShareCast
Physiomics announces new modelling and data scie... 04-Nov-2024 ShareCast
Physiomics secures new contract from existing ph... 17-Sep-2024 ShareCast

Latest Physiomics Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Physiomics Market Data

Currency UK Pounds
Share Price 0.44p
Change Today -0.040p
% Change -8.33 %
52 Week High 1.40
52 Week Low 0.39
Volume 6,850,871
Shares Issued 203.21m
Market Cap £0.89m
Beta 0.02
RiskGrade 504

Physiomics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
26.22% below the market average26.22% below the market average26.22% below the market average26.22% below the market average26.22% below the market average
41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average
Price Trend
90.77% below the market average90.77% below the market average90.77% below the market average90.77% below the market average90.77% below the market average
62.16% below the sector average62.16% below the sector average62.16% below the sector average62.16% below the sector average62.16% below the sector average
Income Not Available
Growth
53.99% below the market average53.99% below the market average53.99% below the market average53.99% below the market average53.99% below the market average
88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average

Physiomics Dividends

No dividends found

Trades for 08-May-2025

Time Volume / Share Price
14:17 350,000 @ 0.43p
14:03 100,000 @ 0.43p
13:44 117,207 @ 0.43p
12:19 300,000 @ 0.43p
11:23 240,000 @ 0.43p

Physiomics Key Personnel

CEO Peter Sargent

Top of Page